News
-
-
PRESS RELEASE
Bone Health Technologies Secures $5 Million in Funding to Transform Osteopenia Care
Bone Health Technologies (BHT) closes oversubscribed $5 million financing round with new investors, including Terumo Medical, to advance Osteoboost wearable vibration device for postmenopausal women's bone health -
PRESS RELEASE
Bone Health Technologies Announces FDA Clearance of OsteoboostTM, the First Prescription Medical Device to Treat Low Bone Density
Bone Health Technologies announces FDA clearance for Osteoboost, a non-pharmacological prescription treatment for postmenopausal women with osteopenia. Osteoboost is a wearable device that delivers targeted vibration to the lumbar spine and hips to reduce bone strength and density decline. This breakthrough technology is safe, medication-free, and has shown efficacy in reducing bone strength loss. The clearance represents a significant advancement in the treatment of low bone density, addressing an underserved need in women's health.
